CAS: 1454925-59-7
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
N-{6-[4-(3-{1-[(4-tert-Butylphenyl)methyl]-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl}propyl)phenyl]pyridin-3-yl}benzenesulfona mide REF: 3D-EIC92559CAS: 1454925-59-7 | Min. 95% | A consultar | Ter 21 Jan 25 | |
NXT629 REF: TM-T12278CAS: 1454925-59-7 | 98% | A consultar | Ter 28 Jan 25 |
N-{6-[4-(3-{1-[(4-tert-Butylphenyl)methyl]-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl}propyl)phenyl]pyridin-3-yl}benzenesulfona mide
CAS:1454925-59-7
N-{6-[4-(3-{1-[(4-tert-Butylphenyl)methyl]-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl}propyl)phenyl]pyridin--3-yl}benzenesulfona mide is a research tool for the study of ion channels. This inhibitor is …
Fórmula:
C35H39N5O3S
Pureza:
Min. 95%
Peso molecular:
609.78 g/mol
Ref: 3D-EIC92559
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |
Entrega estimada em Estados Unidos, Terça-feira 21 de Janeiro de 2025
NXT629
CAS:1454925-59-7
NXT629 is a selective and competitive antagonist of PPAR-α(human PPARα with an IC50 of 77 …
Fórmula:
C35H39N5O3S
Pureza:
98%
Cor e Forma:
Solid
Peso molecular:
609.78
Ref: TM-T12278
5mg | 549,00 € | ||
25mg | 1.549,00 € | ||
50mg | 2.025,00 € | ||
100mg | 2.591,00 € |
Entrega estimada em Estados Unidos, Terça-feira 28 de Janeiro de 2025